Skip to main content

ORIGINAL RESEARCH article

Front. Mol. Biosci., 11 January 2021
Sec. Molecular Diagnostics and Therapeutics
Volume 7 - 2020 | https://doi.org/10.3389/fmolb.2020.603701

RETRACTED: Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles

Retracted

A retraction of this article was approved in:

  1. Retraction: Identification of an immunologic signature of lung adenocarcinomas based on genome-wide immune expression profiles

    1. Read retraction
\nBo Ling&#x;Bo Ling1†Guangbin Ye,&#x;Guangbin Ye1,2†Qiuhua ZhaoQiuhua Zhao1Yan JiangYan Jiang2Lingling LiangLingling Liang1Qianli Tang Qianli Tang3*
  • 1College of Pharmacy, Youjiang Medical University for Nationalities, Baise, China
  • 2Medical College of Guangxi University, Nanning, China
  • 3Key Laboratory of High Incidence of Disease Prevention in the West of Guangxi, Youjiang Medical University for Nationalities, Baise, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Ling B, Ye G, Zhao Q, Jiang Y, Liang L and Tang Q (2021) Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles. Front. Mol. Biosci. 7:603701. doi: 10.3389/fmolb.2020.603701

Received: 07 September 2020; Accepted: 03 December 2020;
Published: 11 January 2021; Retracted: 31 July 2024.

Edited by:

Mahendra Pratap Kashyap, University of Alabama at Birmingham, United States

Reviewed by:

Rakesh Pathak, National Institutes of Health Clinical Center (NIH), United States
Ranganatha R. Somasagara, North Carolina Central University, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.